India, 15th April 2025 – TeleMedC, a Queensland-based leader in AI-powered retinal disease diagnostics is expanding its footprint in India, through a strategic partnership with AND Healthcare Solutions to deliver low-cost, AI-driven eye screening solutions to millions. The move aims to tackle the growing burden of preventable eye diseases by enabling early detection and intervention.
With India’s rising cases of preventable eye diseases and limited access to affordable diagnostic solutions, TeleMedC’s expansion signifies a major step toward improving healthcare accessibility. Through its AI-powered technology, the company enables early detection of conditions such as diabetic retinopathy, glaucoma, and macular diseases, helping to prevent vision impairment and blindness.
On the significance of this partnership, Dr. Jack Tan, Chief Medical Officer, TeleMedC, stated: “Our mission at TeleMedC is to revolutionize primary eye care through AI-driven technology. By partnering with AND Healthcare Solutions, we aim to provide millions of Indians with access to early and effective diagnosis, reducing preventable blindness and enhancing healthcare outcomes. India’s large, dynamic, and fast-moving market presents a significant advantage for a medical technology company like ours. As a respected healthcare hub for neighbouring countries, India also offers strategic importance. Our long-term vision is to refine our R&D products to address the needs of India’s large aging population, focusing on cost-effective chronic disease prevention and management.”
Echoing his sentiments, Mr. Deepak Sharma, CEO, AND Healthcare Solutions Pvt Ltd, added: “We are excited to collaborate with TeleMedC and bring its world-class AI diagnostics to India. With this partnership, we are looking forward to being a part of the transformation in India’s eye-care industry.”
Supported by Trade and Investment Queensland (TIQ), the Queensland Government’s global business agency, TeleMedC and AND Healthcare Solutions will roll out advanced eye imaging and AI-powered diagnostics across India. This initiative is poised to strengthen India’s healthcare innovation ecosystem, making critical eye care more affordable and accessible to all.
Abhinav Bhatia, Senior Trade & Investment Commissioner, TIQ, commented on the development: “Behind every meaningful health innovation lies a partnership rooted in purpose. TeleMedC and AND Healthcare Solutions are demonstrating how international collaboration can bring AI-powered solutions closer to the communities that need them most. This partnership stands as a compelling example of the transformative potential in the Queensland–India corridor. By combining Queensland’s cutting-edge medical technologies with the scale and reach of India’s healthcare ecosystem, these two companies are setting a new benchmark for innovation with impact.”
TeleMedC Targets Screening a Billion Eyes Worldwide, Expands AI Collaborations in India
TeleMedC aims to screen one billion eyes over the next decade, driving early detection, disease prevention, and affordable access to advanced diagnostics. The company is actively partnering with Indian healthcare institutions, research bodies, and non-profits to accelerate innovation in eye health.
Recently, TeleMedC collaborated with leading Indian healthcare institutions, including Aravind Eye Hospital, through the Australia-India Strategic Research Fund. This partnership is advancing AI-driven eye health solutions, reinforcing the company’s commitment to cutting-edge diagnostics.
Expanding its impact, TeleMedC is working with SMEs and large corporations to integrate AI-powered eye screening into Corporate Social Responsibility (CSR) initiatives, making preventive healthcare more inclusive in India.
